Dereck Tatman, Ph.D.

Senior Vice President, Business Development

Dereck Tatman brings over 17 years of industry experience to his role as senior vice president, business development at COI Pharmaceuticals. Dereck has extensive experience in new product and franchise strategy, laboratory operations and corporate infrastructure, international sales, IP licensing, complex dispute resolution as well as strategic corporate partnerships and mergers and acquisitions.

Prior to his role at COI, Dereck served in various roles Sequenom, Inc (acquired by LabCorp), most recently Senior Vice President, Business Development and Operations, where he was responsible for laboratory operations and IT, international sales and domestic managed care relationships and lead efforts to establish non-invasive prenatal testing as a new testing standard in the company and markets around the world.

Dereck received his MBA from the Krannert Schoool of Management at Purdue University.  He received his Ph.D. in chemistry and biochemistry from Arizona State University, where he studied photodynamic therapy, and his B.A. in chemistry from Wabash College.

in the news

  • Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 billion

    read more
  • COI Pharmaceuticals Announces Acquisition of Calporta by Merck

    read more
  • Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK

    read more